Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 2
1(25.0%)
Phase 4
1(25.0%)
4Total
N/A(2)
Phase 2(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05036174Not ApplicableUnknown

Diphenhydramine Ointment for Knee Osteoarthritis

Role: lead

NCT04183387Phase 2Completed

Simvastatin in Uveitis

Role: lead

NCT03530930Phase 4Completed

Comarum Palustre in Knee Osteoarthritis and Diabetes

Role: lead

NCT03540186Not ApplicableUnknown

Epigenorm Antivir Combined With Acupuncture for the Treatment of Osteoarthritis Patients Who Are Overweight or Obese

Role: lead

All 4 trials loaded